Cargando…

Cardiomyocyte protein O-GlcNAcylation is regulated by GFAT1 not GFAT2

In response to cardiac injury, increased activity of the hexosamine biosynthesis pathway (HBP) is linked with cytoprotective as well as adverse effects depending on the type and duration of injury. Glutamine-fructose amidotransferase (GFAT; gene name gfpt) is the rate-limiting enzyme that controls f...

Descripción completa

Detalles Bibliográficos
Autores principales: A Nabeebaccus, Adam, Verma, Sharwari, Zoccarato, Anna, Emanuelli, Giulia, Santos, Celio XC., Streckfuss-Bömeke, Katrin, Shah, Ajay M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606754/
https://www.ncbi.nlm.nih.gov/pubmed/34735873
http://dx.doi.org/10.1016/j.bbrc.2021.10.056
_version_ 1784602403385901056
author A Nabeebaccus, Adam
Verma, Sharwari
Zoccarato, Anna
Emanuelli, Giulia
Santos, Celio XC.
Streckfuss-Bömeke, Katrin
Shah, Ajay M.
author_facet A Nabeebaccus, Adam
Verma, Sharwari
Zoccarato, Anna
Emanuelli, Giulia
Santos, Celio XC.
Streckfuss-Bömeke, Katrin
Shah, Ajay M.
author_sort A Nabeebaccus, Adam
collection PubMed
description In response to cardiac injury, increased activity of the hexosamine biosynthesis pathway (HBP) is linked with cytoprotective as well as adverse effects depending on the type and duration of injury. Glutamine-fructose amidotransferase (GFAT; gene name gfpt) is the rate-limiting enzyme that controls flux through HBP. Two protein isoforms exist in the heart called GFAT1 and GFAT2. There are conflicting data on the relative importance of GFAT1 and GFAT2 during stress-induced HBP responses in the heart. Using neonatal rat cardiac cell preparations, targeted knockdown of GFPT1 and GFPT2 were performed and HBP activity measured. Immunostaining with specific GFAT1 and GFAT2 antibodies was undertaken in neonatal rat cardiac preparations and murine cardiac tissues to characterise cell-specific expression. Publicly available human heart single cell sequencing data was interrogated to determine cell-type expression. Western blots for GFAT isoform protein expression were performed in human cardiomyocytes derived from induced pluripotent stem cells (iPSCs). GFPT1 but not GFPT2 knockdown resulted in a loss of stress-induced protein O-GlcNAcylation in neonatal cardiac cell preparations indicating reduced HBP activity. In rodent cells and tissue, immunostaining for GFAT1 identified expression in both cardiac myocytes and fibroblasts whereas immunostaining for GFAT2 was only identified in fibroblasts. Further corroboration of findings in human heart cells identified an enrichment of GFPT2 gene expression in cardiac fibroblasts but not ventricular myocytes whereas GFPT1 was expressed in both myocytes and fibroblasts. In human iPSC-derived cardiomyocytes, only GFAT1 protein was expressed with an absence of GFAT2. In conclusion, these results indicate that GFAT1 is the primary cardiomyocyte isoform and GFAT2 is only present in cardiac fibroblasts. Cell-specific isoform expression may have differing effects on cell function and should be considered when studying HBP and GFAT functions in the heart.
format Online
Article
Text
id pubmed-8606754
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-86067542021-12-17 Cardiomyocyte protein O-GlcNAcylation is regulated by GFAT1 not GFAT2 A Nabeebaccus, Adam Verma, Sharwari Zoccarato, Anna Emanuelli, Giulia Santos, Celio XC. Streckfuss-Bömeke, Katrin Shah, Ajay M. Biochem Biophys Res Commun Article In response to cardiac injury, increased activity of the hexosamine biosynthesis pathway (HBP) is linked with cytoprotective as well as adverse effects depending on the type and duration of injury. Glutamine-fructose amidotransferase (GFAT; gene name gfpt) is the rate-limiting enzyme that controls flux through HBP. Two protein isoforms exist in the heart called GFAT1 and GFAT2. There are conflicting data on the relative importance of GFAT1 and GFAT2 during stress-induced HBP responses in the heart. Using neonatal rat cardiac cell preparations, targeted knockdown of GFPT1 and GFPT2 were performed and HBP activity measured. Immunostaining with specific GFAT1 and GFAT2 antibodies was undertaken in neonatal rat cardiac preparations and murine cardiac tissues to characterise cell-specific expression. Publicly available human heart single cell sequencing data was interrogated to determine cell-type expression. Western blots for GFAT isoform protein expression were performed in human cardiomyocytes derived from induced pluripotent stem cells (iPSCs). GFPT1 but not GFPT2 knockdown resulted in a loss of stress-induced protein O-GlcNAcylation in neonatal cardiac cell preparations indicating reduced HBP activity. In rodent cells and tissue, immunostaining for GFAT1 identified expression in both cardiac myocytes and fibroblasts whereas immunostaining for GFAT2 was only identified in fibroblasts. Further corroboration of findings in human heart cells identified an enrichment of GFPT2 gene expression in cardiac fibroblasts but not ventricular myocytes whereas GFPT1 was expressed in both myocytes and fibroblasts. In human iPSC-derived cardiomyocytes, only GFAT1 protein was expressed with an absence of GFAT2. In conclusion, these results indicate that GFAT1 is the primary cardiomyocyte isoform and GFAT2 is only present in cardiac fibroblasts. Cell-specific isoform expression may have differing effects on cell function and should be considered when studying HBP and GFAT functions in the heart. Elsevier 2021-12-17 /pmc/articles/PMC8606754/ /pubmed/34735873 http://dx.doi.org/10.1016/j.bbrc.2021.10.056 Text en © 2021 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
A Nabeebaccus, Adam
Verma, Sharwari
Zoccarato, Anna
Emanuelli, Giulia
Santos, Celio XC.
Streckfuss-Bömeke, Katrin
Shah, Ajay M.
Cardiomyocyte protein O-GlcNAcylation is regulated by GFAT1 not GFAT2
title Cardiomyocyte protein O-GlcNAcylation is regulated by GFAT1 not GFAT2
title_full Cardiomyocyte protein O-GlcNAcylation is regulated by GFAT1 not GFAT2
title_fullStr Cardiomyocyte protein O-GlcNAcylation is regulated by GFAT1 not GFAT2
title_full_unstemmed Cardiomyocyte protein O-GlcNAcylation is regulated by GFAT1 not GFAT2
title_short Cardiomyocyte protein O-GlcNAcylation is regulated by GFAT1 not GFAT2
title_sort cardiomyocyte protein o-glcnacylation is regulated by gfat1 not gfat2
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606754/
https://www.ncbi.nlm.nih.gov/pubmed/34735873
http://dx.doi.org/10.1016/j.bbrc.2021.10.056
work_keys_str_mv AT anabeebaccusadam cardiomyocyteproteinoglcnacylationisregulatedbygfat1notgfat2
AT vermasharwari cardiomyocyteproteinoglcnacylationisregulatedbygfat1notgfat2
AT zoccaratoanna cardiomyocyteproteinoglcnacylationisregulatedbygfat1notgfat2
AT emanuelligiulia cardiomyocyteproteinoglcnacylationisregulatedbygfat1notgfat2
AT santoscelioxc cardiomyocyteproteinoglcnacylationisregulatedbygfat1notgfat2
AT streckfussbomekekatrin cardiomyocyteproteinoglcnacylationisregulatedbygfat1notgfat2
AT shahajaym cardiomyocyteproteinoglcnacylationisregulatedbygfat1notgfat2